- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1969
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer’s Disease ; volume:38 ; number:11 ; day:27 ; month:9 ; year:2021 ; pages:951-966 ; date:11.2021
Drugs & aging ; 38, Heft 11 (27.9.2021), 951-966, 11.2021
- Creator
-
Roland, Joshua P.
Bliwise, Donald L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40266-021-00891-1
- URN
-
urn:nbn:de:101:1-2022012522213718770662
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Roland, Joshua P.
- Bliwise, Donald L.
- SpringerLink (Online service)
Other Objects (12)
The effect of insomnia on development of Alzheimer’s disease
Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
A fatal familial insomnia patient initially misdiagnosed as Alzheimer’s disease: a case report
Alzheimer’s Disease
A Framework for Developing Pharmacotherapy for Agitation in Alzheimer’s disease: Recommendations of the ISCTM Working Group
Costs associated with treatment of insomnia in Alzheimer’s disease caregivers: a comparison of mindfulness meditation and cognitive behavioral therapy for insomnia
Alzheimer's disease
Clinical impact of microbleeds in patients with Alzheimer’s disease
Endocytosis and Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Genetics of Alzheimer’s disease
The effect of insomnia on development of Alzheimer’s disease
Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
A fatal familial insomnia patient initially misdiagnosed as Alzheimer’s disease: a case report
Alzheimer’s Disease
A Framework for Developing Pharmacotherapy for Agitation in Alzheimer’s disease: Recommendations of the ISCTM Working Group
Costs associated with treatment of insomnia in Alzheimer’s disease caregivers: a comparison of mindfulness meditation and cognitive behavioral therapy for insomnia
Alzheimer's disease
Clinical impact of microbleeds in patients with Alzheimer’s disease
Endocytosis and Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Genetics of Alzheimer’s disease
The effect of insomnia on development of Alzheimer’s disease
Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
A fatal familial insomnia patient initially misdiagnosed as Alzheimer’s disease: a case report
Alzheimer’s Disease
A Framework for Developing Pharmacotherapy for Agitation in Alzheimer’s disease: Recommendations of the ISCTM Working Group
Costs associated with treatment of insomnia in Alzheimer’s disease caregivers: a comparison of mindfulness meditation and cognitive behavioral therapy for insomnia
Alzheimer's disease
Clinical impact of microbleeds in patients with Alzheimer’s disease
Endocytosis and Alzheimer’s disease
Biomarkers in Alzheimer’s disease